Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
about
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its UseTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Peripheral nociceptor sensitization mediates allodynia in patients with distal symmetric polyneuropathy.5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.Ipsilateral and contralateral sensory changes in healthy subjects after experimentally induced concomitant sensitization and hypoesthesia.Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study.Brain networks predicting placebo analgesia in a clinical trial for chronic back pain.Quantitative sensory testing in pain management.Side effects can enhance treatment response through expectancy effects: an experimental analgesic randomized controlled trial.Tracking local anesthetic effects using a novel perceptual reference approach.Effect of 5% lidocaine medicated plaster on pain intensity and paroxysms in classical trigeminal neuralgia.Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.[Postherpetic neuralgia].Conventional deep pressure algometry is not suitable for clinical assessment of nociception in painless diabetic neuropathy.Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.Localized neuropathic pain: an expert consensus on local treatments.Reliability study of thermal quantitative sensory testing in healthy Chinese.Differential effects of a 5% lidocaine medicated patch in peripheral nerve injury.Management of chronic neuropathic pain with single and compounded topical analgesics.Comparative Analysis of the Effectiveness of the Topical Administration of Benzocaine and EMLA® on Oral Pain and Tactile Sensitivity.Effectiveness of Topical Lidocaine-Prilocaine Cream for Pain Control During Femoral Artery Catheterization in Adult Patients: A Prospective Study.Efficacy of subcutaneous lidocaine injection in venous insufficiency: a prospective, randomized, controlled study, and new treatment protocol.Modalities in managing postherpetic neuralgia
P2860
Q28069535-734C664B-43B0-4CB2-AB58-F19213678467Q34376548-48DB8B42-1B5A-4149-B7E1-C2378CF75181Q34439631-5EEF65AB-0F1B-4C23-A117-40C46A25DE2CQ35752545-74898F6A-13F2-4790-9647-F5FA7651A5F0Q36320939-DAF37302-AB9C-4BCE-8AA5-C72B5B8FEF37Q36329277-3AE932CF-FF25-4C4A-85AF-722E163E3CB7Q36389022-12485F18-E950-4CA7-A9CE-150A95DD40C8Q38591826-908F3DA6-643D-4F26-8405-33D94B3780ACQ38759815-B0A1259E-AA90-4A3F-BDF6-4889F37CFD9DQ38918033-F7FA306C-4C71-4618-B91F-34F4CE3B4EB8Q39152528-1652405B-5000-4028-9600-2ECE2DA8B505Q39191235-34BC9E68-9E5F-4379-B33B-DB192F35A78EQ39194591-2E82AFE3-987D-460E-B138-822009CE3775Q41260980-EC883EDA-2A78-4568-AE3E-3B5F291F8467Q42616506-034DBEE9-F7FD-4F12-84F8-B0CD57C88CB7Q42736007-A9976DC9-C69B-4DEC-894E-F072AE95E5EFQ46051648-4BFC6A4B-0B9A-4E31-8374-B16E68610F40Q48010594-760FCE91-C181-4523-B8EE-22760E5F3218Q50072130-66790211-45CE-48AC-ACAE-598F0C5ADFA2Q52624428-F5C624F0-37D9-410F-82EA-6854905AB896Q55256751-950AC117-41C1-4528-B274-A764B3E0C141Q55424522-2DE08AA3-7AE9-4595-8137-858EB47ABD4DQ57488345-E89B87B3-41BE-473E-BC42-61708958B174
P2860
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@en
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@nl
type
label
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@en
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@nl
prefLabel
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@en
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@nl
P2093
P1433
P1476
Lidocaine patch (5%) produces a selective, but incomplete block of Aδ and C fibers.
@en
P2093
Andrea Westermann
Christoph Maier
Elena K Krumova
Martina Zeller
P304
P356
10.1016/J.PAIN.2011.08.020
P407
P577
2011-10-11T00:00:00Z